Pulmonary Embolism: all 753 studies
Page 8 of 8. Open to participants first (157), then studies with results posted, then the rest; newest registration first within each.
- Inhaled Nitric Oxide in Pulmonary EmbolismCompletedNCT00565253Phase 2
- Risk Stratification for Patients Presenting With Acute Pulmonary Embolism (PE)TerminatedNCT00562042
- 3 Screen Electronic AlertCompletedNCT00550082
- Registry of Hospitalized Patients Treated With FondaparinuxCompletedNCT00549705
- A Phase II Study to Evaluate the Efficacy of ThromboView® in the Detection of Pulmonary EmboliCompletedNCT00519506Phase 2
- Modeling Genotype and Other Factors to Enhance the Safety of Coumadin PrescribingStatus unknownNCT00484640Not applicable
- PREPIC 2 : Prevention of Recurrent Pulmonary Embolism by Vena Cava InterruptionCompletedNCT00457158Phase 4
- Epidemiology of Venous ThromboembolismCompletedNCT00456196
- Home Treatment of Patients With Pulmonary Embolism Based on Pro-Brain Natriuretic Peptide (BNP) LevelsCompletedNCT00455819Not applicable
- Post-marketing Study of Monteplase ("Cleactor") in Patients With Acute Pulmonary EmbolismCompletedNCT00442234Phase 4
- Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese VolunteersCompletedNCT00436787Phase 2
- Safety Study of Outpatient Treatment for Pulmonary EmbolismCompletedNCT00425542Phase 3
- Fondaparinux as Monotherapy for DVT and/or Pulmonary EmbolismCompletedNCT00413504Not applicable
- Multi-Center Human Alert Trial to Prevent DVT and PECompletedNCT00409136
- Evaluation of Obstructive Sleep Apnea as a Risk Factor for Pulmonary EmbolismCompletedNCT00409045
- Deferment of Imaging for Pulmonary EmbolismCompletedNCT00381511Phase 4
- Arixtra PE Study- Outpatient Management of Stable Acute Pulmonary Embolism: Once Daily Subcutaneous FondaparinuxWithdrawnNCT00378027
- Is Using Fondaparinux (Blood Thinner) to Treat Lung Clot Cheaper Than Traditional TherapyWithdrawnNCT00377091Phase 4
- 3 Months' Versus 6 Months' Anticoagulation in Patients With DVT and/or PECompletedNCT00365950Phase 4
- Detection of Pulmonary Embolism With CECTCompletedNCT00351754Phase 4
- Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic ApproachCompletedNCT00345618Phase 3
- A Pharmacogenetic Study of Warfarin Dosing, "The COUMA-GEN Study"CompletedNCT00334464Not applicable
- VITRO-Trial. B Vitamins and the Secondary Prevention of Venous ThrombosisCompletedNCT00314990Not applicable
- Catheter Thrombectomy in Patients With Massive Pulmonary EmbolismTerminatedNCT00314002Phase 1/2
- Study of Diagnosis and Pathophysiology of Pulmonary Embolism (APE 1 Trial)TerminatedNCT00302601Not applicable
- D-dimer Levels During and After Anticoagulation in Patients With a Previous Venous Thromboembolism: Effects on the Risk of RecurrenceCompletedNCT00266045
- D-dimer to Establish Duration of Anticoagulation After Venous ThromboembolismCompletedNCT00264277Phase 4
- Prospective Investigation of Pulmonary Embolism Diagnosis IIICompletedNCT00241826
- Protection From Pulmonary Embolism With the Permanent OptEase™ Filter (PROOF)CompletedNCT00233740Phase 4
- Aspirin for the Prevention of Recurrent Venous ThromboembolismStatus unknownNCT00222677Phase 2/3
- Tenecteplase Pulmonary Embolism Italian StudyTerminatedNCT00222651Phase 2
- Home Treatment of Pulmonary EmbolismStatus unknownNCT00214929Phase 4
- SHORTness of Breath In the Emergency Department (SHORTIE)CompletedNCT00206830Phase 2/3
- Study of IVC Filter Retrieval With the Günther Tulip Vena Cava FilterCompletedNCT00196118Phase 4
- Strategies for Suspected Pulmonary Embolism in Emergency DepartmentsCompletedNCT00188032Not applicable
- The D-KAF (Dalteparin in Knee-to-Ankle Fracture) TrialCompletedNCT00187408Phase 4
- Use of Low Molecular Weight Heparin (Tinzaparin) to Treat Blood Clots in Patients With Kidney FailureTerminatedNCT00186745Not applicable
- Canadian Pulmonary Embolism Diagnosis Study (CANPEDS)TerminatedNCT00182546Phase 3
- Fixed Dose Heparin StudyCompletedNCT00182403Phase 3
- D-Dimer and IPG for Recurrent Thrombosis (DIRECT)TerminatedNCT00182247Phase 3
- Genetic Determinants of Warfarin Anticoagulation EffectStatus unknownNCT00162435Not applicable
- Multi-Detector Spiral Computed Tomography Alone Versus Combined Strategy With Lower Limb Compression Ultrasonography in Outpatients Suspected of Pulmonary EmbolismCompletedNCT00117169Not applicable
- Venous Blood Flow Velocity: Electrical Foot Stimulation Compared to Intermittent Pneumatic Compression of the FootCompletedNCT00114608Phase 1
- BMS-562247 in Subjects Undergoing Elective Total Knee Replacement SurgeryCompletedNCT00097357Phase 2/3
- Identifying Low-Risk Patients With Pulmonary EmbolismCompletedNCT00086151
- SR34006 Compared to Placebo in Patients Who Have Completed 6 Months of Treatment for Symptomatic Pulmonary Embolism or Deep Vein ThrombosisCompletedNCT00071279Phase 3
- SR34006 Compared to Vitamin K Antagonist (VKA) in the Treatment of Pulmonary EmbolismCompletedNCT00062803Phase 3
- Risk Factors for Venous ThromboembolismCompletedNCT00018772
- Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED II)CompletedNCT00007085Not applicable
- Epidemiology of Venous Thrombosis and Pulmonary EmbolismActive, not recruitingNCT00005504
- Incidence and Outcomes of Venous ThromboembolismCompletedNCT00005351
- Nurses' Health Study (Cardiovascular Component)Active, not recruitingNCT00005152
- Prospective Investigation of Pulmonary Embolism Diagnosis (PIOPED)CompletedNCT00000566Phase 3